Compare · PBAX vs PLBL
PBAX vs PLBL
Side-by-side comparison of Phoenix Biotech Acquisition Corp. (PBAX) and Polibeli Group Ltd (PLBL): market cap, price performance, sector, and recent activity on the wire.
Summary
- PBAX operates in Industrials, while PLBL operates in Consumer Discretionary - the two are in different parts of the market.
- PLBL is the larger of the two at $2.76B, about 12.1x PBAX ($227.7M).
- PLBL has hit the wire 2 times in the past 4 weeks while PBAX has been quiet.
- Company
- Phoenix Biotech Acquisition Corp.
- Polibeli Group Ltd
- Price
- $5.45+14.26%
- $7.68-1.16%
- Market cap
- $227.7M
- $2.76B
- 1M return
- -
- -4.71%
- 1Y return
- -
- -8.13%
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 0
PBAX
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)
Latest PLBL
- Polibeli Signs Non-Binding MOU to Evaluate Potential AI Data Center Opportunity in Indonesia
- SEC Form 6-K filed by Polibeli Group Ltd
- SEC Form 6-K filed by Polibeli Group Ltd
- Polibeli Signs Non-Binding MOU to Evaluate Potential 100 MW AI Computing Center Project in Thailand
- SEC Form EFFECT filed by Polibeli Group Ltd
- SEC Form F-1 filed by Polibeli Group Ltd
- SEC Form 6-K filed by Polibeli Group Ltd
- SEC Form 3 filed by new insider Liang Meijun
- SEC Form 6-K filed by Polibeli Group Ltd
- SEC Form 6-K filed by Polibeli Group Ltd